why the whooosh, page-14

re: re jo jo sydney Hi dma,

I agree with your post and yet Biota looks promising and worth another look.
Last year I took the punt because of the bird flu scenario and had my expactations to high.
This was mainly because of the lack of support by GSK to produce adequate Relenza to gain market share.

Today GSK has been reluctantly increasing production but still by far not enough to make the most of the current demand for Relenza.

The other projects in the pipeline performing nicely but it takes time to reap the fruits of these.

I still have no idea how long LANI is going to take before it will be brought onto the market and we can only hope that once that happens that its going as succesfull as we all made to believe.

But as I have said before I keep a close eye and at the right time jump back in.

Good luck and yes you are a true believer dma

jojo